Telehealth Assessment and Skill-Building Kit (TASK III) Group for Stroke

Phase-Based Progress Estimates
Stroke+1 MoreTelehealth Assessment and Skill-Building Kit (TASK III) Group - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial sought to find out if the TASK III intervention could reduce the burden on caregivers of stroke survivors.

Eligible Conditions
  • Stroke
  • Family Caregivers

Treatment Effectiveness

Study Objectives

1 Primary · 7 Secondary · Reporting Duration: Baseline to 8 weeks (shortterm), baseline to 12, 24, and 52 weeks (long-term)

12 weeks
Program Evaluation Outcomes: Satisfaction
Program Evaluation Outcomes: Technology
Week 52
Life Changes
Week 52
Depressive Symptoms
Healthcare Utilization
Mediator: Self-efficacy of Diet
Mediator: Self-efficacy of Exercise
Mediator: Task Difficulty
Mediator: Threat Appraisal
Other Symptoms
Self-management of Diet
Self-management of Exercise
Self-management of Steps
Unhealthy Days

Trial Safety

Trial Design

2 Treatment Groups

ISR Group
1 of 2
1 of 2

Active Control

Experimental Treatment

296 Total Participants · 2 Treatment Groups

Primary Treatment: Telehealth Assessment and Skill-Building Kit (TASK III) Group · No Placebo Group · N/A

Experimental Group · 1 Intervention: Telehealth Assessment and Skill-Building Kit (TASK III) Group · Intervention Types: Behavioral
ISR Group
ActiveComparator Group · 1 Intervention: Information Support and Referral (ISR) Group · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to 8 weeks (shortterm), baseline to 12, 24, and 52 weeks (long-term)

Who is running the clinical trial?

National Institute of Nursing Research (NINR)NIH
529 Previous Clinical Trials
10,287,273 Total Patients Enrolled
14 Trials studying Stroke
6,818 Patients Enrolled for Stroke
University of CincinnatiLead Sponsor
389 Previous Clinical Trials
635,443 Total Patients Enrolled
26 Trials studying Stroke
13,439 Patients Enrolled for Stroke
Tamilyn Bakas, PhD, RNPrincipal InvestigatorUniversity of Cincinnati
1 Previous Clinical Trials
74 Total Patients Enrolled
1 Trials studying Stroke
74 Patients Enrolled for Stroke

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have no hearing or speech difficulties.\n
You have a score of 4 or more on a 6-item cognitive impairment screener.